Ovarian Carcinoma: Clinical Validity by Simultaneous Determination of Fibrin Degradation Products with the DR-70™ Immunoassay and CA-125 - Schaffrath, M; Harter, P; Wulgaris, S; Seufert, R; du Bois, A; Pollow, K (Geburtshilfe und Frauenheilkunde, 2006)